 |
인쇄하기
취소
|
Ildong announces combination product license agreement with Ajinomoto
Ildong Pharm last Thursday announced that it has entered into a commercial license agreement with Ajinomoto Pharmaceutical Co. to market a combination drug containing cilnidipine and valsartan in Korea.
Ildong is expected to launch the combination drug in 2015 after carrying out clinical trial with three dosage strengths (10 mg/80 mg, 5 mg/80 mg and 10 mg/160 mg). The company plans to raise ...
Ildong is expected to launch the combination drug in 2015 after carrying out clinical trial with three dosage strengths (10 mg/80 mg, 5 mg/80 mg and 10 mg/160 mg). The company plans to raise ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.